ACOG第822号委员会意见:疑似子宫肌瘤的子宫粉碎术
ACOG第822号委员会意见讨论疑似子宫肌瘤手术中使用粉碎术的风险与决策。粉碎术可缩小组织以便小切口或腹腔镜取出,但可能播散未疑及的平滑肌肉瘤。术前无法可靠诊断平滑肌肉瘤,需评估恶性风险并共享决策。
要点
- 粉碎术前应评估子宫体恶性肿瘤风险,恶性者禁用粉碎术。
- 平滑肌肉瘤术前无法可靠诊断,粉碎可能播散恶性肿瘤。
- 开腹手术可降低播散风险但并发症高于微创,需共享决策。
核心结论
- 疑似子宫肌瘤粉碎术前应评估恶性风险,恶性者禁用粉碎术。
- 平滑肌肉瘤术前无法可靠诊断,粉碎存在播散恶性肿瘤的风险。
- 医患应共享决策并知情同意,说明各手术方式及粉碎术的风险获益与替代方案。
研究设计与样本
- 美国妇产科医师学会(ACOG)制定的委员会意见,非系统综述或原始研究。
主要发现
- 开腹子宫切除术或肌瘤剔除术可降低未诊断平滑肌肉瘤的癌细胞播散机会,但并发症高于微创手术。
- 粉碎术通过缩小组织以便小切口或腹腔镜取出,但可能播散未疑及的平滑肌肉瘤。
- 平滑肌肉瘤无法术前可靠诊断,因此疑似肌瘤患者可能存在经粉碎播散的恶性肿瘤。
关键数值与推荐
- 恶性肿瘤的粉碎术为禁忌。
- 考虑子宫粉碎术前应评估患者是否存在子宫体恶性肿瘤风险增加。
临床怎么用
- 术前评估子宫体恶性肿瘤风险,恶性者禁用粉碎术。
- 与患者共享决策并知情同意,说明粉碎术风险获益及替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Morcellation is a surgical technique used to reduce the size of the uterus or myomas by creating smaller pieces to allow the tissue to be removed through small incisions or with laparoscopic instruments. Open (uncontained) morcellation of the uterus and myomas has been scrutinized because of the possible spread of an unsuspected leiomyosarcoma while using a power morcellator during a hysterectomy or myomectomy for presumed symptomatic uterine leiomyomas. Before considering morcellation of the uterus, a woman should be evaluated to determine if she is at increased risk of malignancy of the uterine corpus. Morcellation of a malignancy is contraindicated and women should be evaluated preoperatively to identify malignancy. However, leiomyosarcoma cannot be reliably diagnosed preoperatively; thus, there is a risk that a woman with a presumed leiomyoma may have a malignancy that may be spread through morcellation, leading to a potentially worsened prognosis. Although an abdominal hysterectomy or myomectomy may reduce the chance of spreading cancer cells in women with undiagnosed leiomyosarcoma, it is associated with increased morbidity when compared with minimally invasive approaches. The obstetrician-gynecologist and patient should engage in shared decision making, including informed consent, explaining the risks and benefits of each approach to surgery for presumed leiomyomas, the risks and benefits of morcellation, and alternatives to morcellation.
引用
- Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822. Obstet Gynecol. 2021. PMID: 33595252. doi:10.1097/AOG.0000000000004291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。